JP2004248508A5 - - Google Patents

Info

Publication number

JP2004248508A5

JP2004248508A5 JP2002323177A JP2002323177A JP2004248508A5 JP 2004248508 A5 JP2004248508 A5 JP 2004248508A5 JP 2002323177 A JP2002323177 A JP 2002323177A JP 2002323177 A JP2002323177 A JP 2002323177A JP 2004248508 A5 JP2004248508 A5 JP 2004248508A5

Authority

JP

Japan

Prior art keywords

seq

nucleotide sequence

primer

human

pcr

Prior art date

2002-09-30

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 239000002773 nucleotide Substances 0.000 claims 43
• 125000003729 nucleotide group Chemical group 0.000 claims 43
• 238000000034 method Methods 0.000 claims 30
• 101000951365 Homo sapiens Disks large-associated protein 5 Proteins 0.000 claims 21
• 238000010240 RT-PCR analysis Methods 0.000 claims 17
• 206010005003 Bladder cancer Diseases 0.000 claims 14
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 14
• 201000005112 urinary bladder cancer Diseases 0.000 claims 14
• 239000012472 biological sample Substances 0.000 claims 12
• 238000001514 detection method Methods 0.000 claims 9
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 8
• 230000003321 amplification Effects 0.000 claims 8
• 108020004999 messenger RNA Proteins 0.000 claims 8
• 238000003199 nucleic acid amplification method Methods 0.000 claims 8
• 210000004027 cell Anatomy 0.000 claims 6
• 230000014509 gene expression Effects 0.000 claims 6
• 206010044412 transitional cell carcinoma Diseases 0.000 claims 6
• 238000003752 polymerase chain reaction Methods 0.000 claims 5
• 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 4
• 238000007834 ligase chain reaction Methods 0.000 claims 4
• 210000002700 urine Anatomy 0.000 claims 4
• 108091028043 Nucleic acid sequence Proteins 0.000 claims 3
• 238000009007 Diagnostic Kit Methods 0.000 claims 2
• 238000001574 biopsy Methods 0.000 claims 2
• 210000004369 blood Anatomy 0.000 claims 2
• 239000008280 blood Substances 0.000 claims 2
• 230000000295 complement effect Effects 0.000 claims 2
• 230000001351 cycling effect Effects 0.000 claims 2
• 102000045085 human DLGAP5 Human genes 0.000 claims 2
• 238000009396 hybridization Methods 0.000 claims 2
• 238000000338 in vitro Methods 0.000 claims 2
• 238000007403 mPCR Methods 0.000 claims 2
• 230000001404 mediated effect Effects 0.000 claims 2
• 238000007857 nested PCR Methods 0.000 claims 2
• 150000007523 nucleic acids Chemical group 0.000 claims 2
• 210000002381 plasma Anatomy 0.000 claims 2
• 238000007894 restriction fragment length polymorphism technique Methods 0.000 claims 2
• 239000000523 sample Substances 0.000 claims 2
• 210000002966 serum Anatomy 0.000 claims 2
• 238000013518 transcription Methods 0.000 claims 2
• 230000035897 transcription Effects 0.000 claims 2
• 238000012544 monitoring process Methods 0.000 claims 1